共 101 条
[71]
Arikan S., Current status of antifungal susceptibility testing methods, Med. Mycol., 45, pp. 569-587, (2007)
[72]
Lass-Florl C., Cuenca-Estrella M., Denning D.W., Et al., Antifungal susceptibility testing in Aspergillus spp. according to EUCAST methodology, Med. Mycol., 44, pp. 319-325, (2006)
[73]
Petrikkou E., Rodri J.L., Gomez A., Et al., Inoculum standardization for antifungal susceptibility testing of filamentous fungi pathogenic for humans, J. Clin. Microbiol., 39, pp. 1345-1347, (2001)
[74]
Aberkane A., Cuenca-Estrella M., Gomez-Lopez A., Et al., Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi, J. Antimicrob. Chemother., 50, pp. 719-722, (2002)
[75]
CLSI, Methods for Determining Bactericidal Activity of Antimicrobial Agents. Approved Guideline, CLSI Document M26-A, (1998)
[76]
Canton E., Peman J., Viudes A., Et al., Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species, Diagn. Microbiol. Infect. Dis., 45, pp. 203-206, (2003)
[77]
Espinel-Ingroff A., Fothergill A., Peter J., Et al., Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study, J. Clin. Microbiol., 40, pp. 3204-3208, (2002)
[78]
Espinel-Ingroff A., Chaturvedi V., Fothergill A., Et al., Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study, J. Clin. Microbiol., 40, pp. 3776-3781, (2002)
[79]
CLSI, Methods for Antimicrobial Dilution and Disk Susceptibility of Infrequently Isolated or Fastidious Bacteria, Approved Guideline, CLSI Document M45-A2, (2010)
[80]
Menon T., Umamaheswari K., Kumarasamy N., Et al., Efficacy of fluconazole and itraconazole in the treatment of oral candidiasis in HIV patients, Acta Trop., 80, pp. 151-154, (2001)